ACE and Alzheimer disease: Neuropsychiatric markers of progression (e.g. ACE III) were more sensitive in CBS-AD, while activities of daily living (e.g. SEADL) and quality of life (e.g. PSP-QoL) markers were more sensitive in CBS-4RT.